Glucagon-like Peptide 1-Based Drugs and Pancreatic Safety

被引：1
作者：
Raschi, Emanuel [1 ]
Piccinni, Carlo [1 ]
Marchesini, Giulio [1 ]
机构：
[1] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
来源：
JAMA INTERNAL MEDICINE | 2013年 / 173卷 / 19期
关键词：
RISK;
D O I：
10.1001/jamainternmed.2013.8150
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1843 / 1843
页数：1
相关论文
共 50 条
[31]   Impact of Glucagon-Like Peptide 1 Receptor Agonists on Biochemical Markers of the Initiation of Atherosclerotic Process [J].
Hachula, Marcin ;
Kosowski, Michal ;
Ryl, Sabina ;
Basiak, Marcin ;
Okopien, Boguslaw .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
[32]   Safety and efficacy of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese non-diabetic patients [J].
Singh, Sahib ;
Garg, Aakash ;
Tantry, Udaya S. ;
Bliden, Kevin ;
Gurbel, Paul A. ;
Gulati, Martha .
CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (03)
[33]   Cardiovascular effects of alpha-linolenic acid - a possible role of glucagon-like peptide-1 [J].
Sonne, David P. ;
Knop, Filip K. .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2013, 238 (10) :1116-1117
[34]   Glucagon-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes [J].
Simon, Tracey G. ;
Patorno, Elisabetta ;
Schneeweiss, Sebastian .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (06) :1382-+
[35]   An impaired glucagon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity [J].
Ferjan, Simona ;
Jensterle, Mojca ;
Oblak, Tjasa ;
Zitnik, Irena Prodan ;
Marc, Janja ;
Goricar, Katja ;
Dolzan, Vita ;
Janez, Andrej .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (10) :4691-4700
[36]   Comment on: Association Between Glucagon-Like Peptide 1 Receptor Agonists Exposure and Intraocular Pressure Change [J].
Tang, Wei-zhen ;
Chen, Hao-wen ;
Liu, Tai-hang .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2025, 270 :273-274
[37]   Glucagon-like peptide 1 receptor agonists and renal outcomes in kidney transplant recipients with diabetes mellitus [J].
Cohen, Talia Diker ;
Rudman, Yaron ;
Turjeman, Adi ;
Akirov, Amit ;
Steinmetz, Tali ;
Calvarysky, Bronya ;
Dotan, Idit .
DIABETES & METABOLISM, 2025, 51 (03)
[38]   Glucagon-Like Peptide-1 Receptor Agonists and Diabetic Cardiovascular Disease: Implications of the LEADER Study [J].
Swislocki, Arthur L. M. ;
Jialal, Ishwarlal .
METABOLIC SYNDROME AND RELATED DISORDERS, 2016, 14 (08) :375-377
[39]   Glucagon-Like Peptide-1 and Blood Pressure in Young and Healthy Adults from the General Population [J].
Krisai, Philipp ;
Aeschbacher, Stefanie ;
Schoen, Tobias ;
Bossard, Matthias ;
van der Stouwe, Jan Gerrit ;
Dorig, Laura ;
Todd, John ;
Estis, Joel ;
Risch, Martin ;
Risch, Lorenz ;
Conen, David .
HYPERTENSION, 2015, 65 (02) :306-312
[40]   Role of intestinal glucagon-like peptide-1 in impaired counter-regulatory responses to hypoglycemia [J].
Dodamani, Manjunath Havalappa ;
Hatwal, Juniali ;
Batta, Akash .
WORLD JOURNAL OF DIABETES, 2024, 15 (12)
12345